Pyeloplasty for Ureteropelvic Junction (UPJ) Obstruction
Treatment for Urogenital Congenital Anomalies
Effectiveness
96%
Safety Score
65%
Clinical Trials
350
Participants
18K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
65
DangerousModerateSafe
Treatment Details
Time to Effect
Immediate anatomical correction, functional improvement over months
Treatment Duration
Single surgery, stent for 2-6 weeks, follow-up for several years
Evidence Quality
HIGHConfidence Score
92%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$150
Monitoring:$4,500
Side Effect Mgmt:$1,000
Total Annual:$22,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTQALYs Gained
1.5
Outcome-Based Costs
Cost per Responder
$22,917
Comparison vs Watchful Waiting (for asymptomatic, mild cases)
Cost Difference
$0/year
Same cost
QALY Difference
+1.50 QALYs
Better outcomes
Dominance
DOMINATESBetter + cheaper
Pyeloplasty for Ureteropelvic Junction (UPJ) Obstruction Outcomes
for Urogenital Congenital Anomalies
Efficacy Outcomes
Overall Effectiveness
+96%
Response Rate
+96%
Common Side Effects
Urinary leak (requiring drainage)
+3%
Urinary tract infection
+3%
Persistent obstruction (failure)
+4%
Bleeding
+1%
Post-operative pain
+20%
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov